<code id='7CACDC7C0E'></code><style id='7CACDC7C0E'></style>
    • <acronym id='7CACDC7C0E'></acronym>
      <center id='7CACDC7C0E'><center id='7CACDC7C0E'><tfoot id='7CACDC7C0E'></tfoot></center><abbr id='7CACDC7C0E'><dir id='7CACDC7C0E'><tfoot id='7CACDC7C0E'></tfoot><noframes id='7CACDC7C0E'>

    • <optgroup id='7CACDC7C0E'><strike id='7CACDC7C0E'><sup id='7CACDC7C0E'></sup></strike><code id='7CACDC7C0E'></code></optgroup>
        1. <b id='7CACDC7C0E'><label id='7CACDC7C0E'><select id='7CACDC7C0E'><dt id='7CACDC7C0E'><span id='7CACDC7C0E'></span></dt></select></label></b><u id='7CACDC7C0E'></u>
          <i id='7CACDC7C0E'><strike id='7CACDC7C0E'><tt id='7CACDC7C0E'><pre id='7CACDC7C0E'></pre></tt></strike></i>

          Home / hotspot / hotspot

          hotspot


          hotspot

          author:hotspot    Page View:81614
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In